Page 15 - 《中国药房》2024年1期

Chinese Society of Clinical Pharmacy，Hospital Pharmacy Branch of the Chinese Medical Association. Guide to the
Committee of the Chinese Pharmaceutical Association， use of iodine contrast agents：2nd edition [J]. Natl Med J
Nephrology Branch of the Chinese Medical Association. China，2014，94（43）：3363-3369.
Expert consensus on prevention and treatment of iodine [13] YAMAGUCHI K，KATAYAMA H，TAKASHIMA T，
contrast media-induced acute kidney injury[J]. Chin J et al. Prediction of severe adverse reactions to ionic and
Nephrol，2022，38（3）：265-288. nonionic contrast media in Japan：evaluation of pretesting.
[ 5 ] WEI Y，HE Z，ZHANG C，et al. Cost-minimization analy‐ A report from the Japanese Committee on the Safety of
sis of multidose and single-dose packaging of contrast me‐ Contrast Media[J]. Radiology，1991，178（2）：363-367.
dia for contrast-enhanced CT：results from real-world data [14] LASSER E C，BERRY C C，MISHKIN M M，et al. Pre‐
in China[J]. AJR Am J Roentgenol，2020，215：（1）：5-14. treatment with corticosteroids to prevent adverse reactions
[ 6 ] MACDONALD D B，HURRELL C D，COSTA A F，et al. to nonionic contrast media[J]. AJR Am J Roentgenol，
Canadian Association of Radiologists guidance on 1994，162（3）：523-526.
contrast-associated acute kidney injury[J]. Can J Kidney [15] DAVENPORT M S，KHALATBARI S，COHAN R H，
Health Dis，2022，9：20543581221097455. et al. Contrast material-induced nephrotoxicity and intra‐
[ 7 ] PERNER A，PROWLE J，JOANNIDIS M，et al. Fluid venous low-osmolality iodinated contrast material：risk
management in acute kidney injury[J]. Intensive Care stratification by using estimated glomerular filtration rate
Med，2017，43（6）：807-815. [J]. Radiology，2013，268（3）：719-728.
[ 8 ] WHITING P，MORDEN A，TOMLINSON L A，et al. [16] MCDONALD R J，MCDONALD J S，BIDA J P，et al. In‐
What are the risks and benefits of temporarily disconti- travenous contrast material-induced nephropathy：causal
nuing medications to prevent acute kidney injury? A sys‐ or coincident phenomenon? [J]. Radiology，2016，278
tematic review and meta-analysis[J]. BMJ Open，2017，7 （1）：306.
（4）：e012674. [17] MCDONALD J S，MCDONALD R J，CARTER R E，
[ 9 ] ORLACCHIO A，GUASTONI C，BERETTA G D，et al. et al. Risk of intravenous contrast material-mediated acute
SIRM-SIN-AIOM：appropriateness criteria for evaluation kidney injury：a propensity score-matched study stratified by
and prevention of renal damage in the patient undergoing baseline-estimated glomerular filtration rate[J]. Radiology，
contrast medium examinations-consensus statements from 2014，271（1）：65-73.
Italian College of Radiology （SIRM），Italian College of [18] 中华医学会放射学分会质量控制与安全管理专业委员
Nephrology （SIN） and Italian Association of Medical On‐ 会. 肾病患者静脉注射碘对比剂应用专家共识[J]. 中华
cology （AIOM）[J]. Radiol Med，2022，127（5）：534-542. 放射学杂志，2021，55（6）：580-590.
[10] HWANG E J，SHIN C I，CHOI Y H，et al. Frequency，out‐ Quality Control and Safety Management Committee of
come，and risk factors of contrast media extravasation in the Radiology Branch of the Chinese Medical Association.
142 651 intravenous contrast-enhanced CT scans[J]. Eur Expert consensus of iodinated contrast agent use in pa‐
Radiol，2018，28（12）：5368-5375. tients with renal diseases[J]. Chin J Radiol，2021，55（6）：
[11] PLUMB A A，MURPHY G. The use of central venous 580-590.
catheters for intravenous contrast injection for CT exami‐ [19] HIREMATH S，AKBARI A，SHABANA W，et al. Preven‐
nations[J]. Br J Radiol，2011，84（999）：197-203. tion of contrast-induced acute kidney injury：is simple oral
[12] 中华医学会放射学分会对比剂安全使用工作组. 碘对比 hydration similar to intravenous? A systematic review of
剂使用指南：第 2 版[J]. 中华医学杂志，2014，94（43）： the evidence[J]. PLoS One，2013，8（3）：e60009.
3363-3369. （收稿日期：2023-08-08 修回日期：2023-11-27）
Contrast Media Safety Committee of the Radiology （编辑：林 静）

中国药房 2024年第35卷第1期 China Pharmacy 2024 Vol. 35 No. 1 · 9 ·